PXL/HO/Cir-012/2025-26                                            Date: 26.04.2025

Hyderabad

SUBJECT: Market Study on Pharmaceutical Sector in Kuwait” by Embassy of India, Kuwait - also a request to Pharmexcil delegation to Kuwait.

We are pleased to inform that the Embassy of India, Kuwait has commissioned “Market Study on Pharmaceutical Sector in Kuwait”, through  a reputed consultancy firm, Marmore MENA. The report highlights a significant potential for Indian pharmaceutical products and medical devices in the Kuwaiti market. The detailed study outlines key trends, regulatory frameworks, and strategic areas where Indian exporters can find meaningful entry and expansion opportunities.

Key Insights from the Study & Recent Developments:

• The Kuwaiti government is actively working on a pharmaceutical manufacturing strategy to develop a competitive, export-oriented industry.
• Focus areas include:
  • High-quality drug formulations (excluding API manufacturing at present).
  • Joint venturesfor local biosimilar production.
  • Localization of packaging materialsfor medicines and medical supplies.
  • Attracting multinational companies through offset programs.
  • Expansion of supply contracts to support local manufacturers.
  • Incentive and support programs for local producers.
  • Adoption of innovative technologies such as continuous manufacturing and modular factory design.
  • Promotion of industry-academia collaboration via research clusters.

The full report is attached herewith for your reference. You may like to share your feedback on the Study Report with us at dgdesk@pharmexcil.com  and regulatory@pharmexcil.com

With best regards,

Raja Bhanu

Director General 

ENCL: REPORT